296/2004 on the Consumer Code, with its subsequent amendments and completions, corroborated with the provisions of Law No
RELATED: Who can take Rybelsus for weight loss
Novo Nordisk's Wegovy savings program is designed for commercially insured patients filling prescriptions at retail pharmacies
Third, long-term safety and efficacy data beyond several months of treatment is lacking
While that decision will vary based on each companys operations and supply chain, these providers should not be ordering, prescribing, or dispensing semaglutide injection products after April 22, 2025, if those products come from a 503A compounding pharmacy, or after May 22, 2025, if those products come from a 503B outsourcing facility